Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David A. Ebersman currently holds 58,138 shares of GENENTECH INC (DNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David A. Ebersman has been a net seller of DNA stock. They have purchased $0 and sold $142.4M worth of shares.
David A. Ebersman's most recent insider trade was on May 31, 2023, when they sold 58,138 shares at $0.00 per share.
David A. Ebersman serves as Executive at GENENTECH INC (DNA). They have executed 219 insider transactions totaling $142.4M over their tenure at the company.
David A. Ebersman holds the position of Executive at GENENTECH INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
David A. Ebersman has shown a selling trading pattern, with $0 in total purchases and $142.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David A. Ebersman was on Mar 17, 2014, when they sold $4.0M worth of FB shares. This transaction involved 58,714 shares at $68.12 per share.
David A. Ebersman currently owns 58,138 shares of GENENTECH INC (DNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David A. Ebersman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David A. Ebersman has 219 Form 4 filings on record as an insider at GENENTECH INC.
Set alerts for David A. Ebersman and 40,000+ other insiders.